journal article·2022-09-21Open access

Adult Asthma Management in the Emergency Department during COVID-19 Pandemic: An Expert Opinion Survey

Maurizio Gabrielli, Angela Saviano, Matteo Bonini, Cristina Boccabella, Cristiano Caruso, Maria Pia Ruggieri, Simone Bianconi, Leonello Fuso, Pietro Capuzi, Francesca De Marco, Laura Franza, Francesco Franceschi

Applied Sciences· Volume 12· Issue 19

Abstract

Adult patients with asthma often access the emergency department (ED) for the management of exacerbations or uncontrolled symptoms. Sometimes the first diagnosis of asthma occurs right in the ED. In the last couple of years, the COVID-19 pandemic spread around the world, causing an acute respiratory syndrome named SARS-CoV-2, characterized mainly by respiratory symptoms, such as cough and shortness of breath, in addition to fever. This clinical pattern partially overlaps with that caused by asthma, thus generating confusion in terms of diagnosis and management. It is also unclear whether asthma may be associated with a worse prognosis in COVID-19 infection. This expert opinion paper provides specific recommendations to ease the challenges related to adult patients with asthma admitted to the ED during the COVID-19 pandemic, with particular reference to diagnosis and treatment. Moreover, it provides well-defined indications to guide decisions on discharge, hospital admission, as well as follow-up. A panel of experts composed of emergency medicine physicians, pulmonologists and allergologists discussed, voted and approved all the recommendations.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: COVID-19 and healthcare impacts · Respiratory Support and Mechanisms · Chronic Obstructive Pulmonary Disease (COPD) Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Dipartimento di Scienze dell’Emergenza, Anestesiologiche e della Rianimazione, Fondazione Policlinico Universitario A. Gemelli IRCCS—Università Cattolica del Sacro Cuore, 00168 Rome, Italy

Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS—Università Cattolica del Sacro Cuore, 00168 Rome, Italy

Dipartimento di Emergenza, Azienda Ospedaliera San Giovanni Addolorata, 00184 Rome, Italy

Dipartimento di Medicina Interna, Azienda Ospedaliera San Giovanni Addolorata, 00184 Rome, Italy

Dipartimento di Emergenza, Ospedale San Pietro Fatebenefratelli, 00189 Rome, Italy

Funding

Novartis Farma S.p.A.

References (96)

Show source-provided references
2. Diagnosis and Management of Asthma in Adults: A Review10.1001/jama.2017.8372 ↗
3. Global Initiative for Asthma Strategy 2021: Executive summary and rationale for key changes10.1183/13993003.02730-2021 ↗
4. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma10.1183/09031936.00202013 ↗
5. Pharmacoeconomic management of patient with severe asthma in the Emergency Department: Retrospective multicentric and cost of illness study
6. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review10.1001/jama.2020.12839 ↗
7. Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation10.1016/j.ajem.2022.01.028 ↗
8. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: A multicentre prospective observational study10.1016/S2213-2600(20)30370-2 ↗
9. Non-COVID-19 admissions to the emergency department during the pandemic second wave in Italy: What is changed from the first wave?10.1016/j.ajem.2020.11.046 ↗
10. Role of viral respiratory infections in asthma and asthma exacerbations10.1016/S0140-6736(10)61380-3 ↗
11. MERS, SARS and other coronaviruses as causes of pneumonia10.1111/resp.13196 ↗
12. Asthma in patients admitted to emergency department for COVID-19: Prevalence and risk of hospitalization10.1007/s11739-021-02868-9 ↗
13. Asthma does not influence the severity of COVID-19: A meta-analysis10.1080/02770903.2021.1917603 ↗
14. How to use the nominal group and Delphi techniques
15. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department10.1080/1354750X.2021.1876769 ↗
16. Hanson, K.E., Altayar, O., Caliendo, A.M., Arias, C.A., Englund, J.A., Hayden, M.K., Lee, M.J., Loeb, M., Patel, R., and El Alayli, A. (2021). The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing. Clin. Infect. Dis.10.1093/cid/ciab557 ↗
17. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program10.1001/jama.2020.21974 ↗
18. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases10.1148/radiol.2020200642 ↗
19. COVID-19 pneumonia: What has CT taught us?10.1016/S1473-3099(20)30134-1 ↗
20. Portable chest X-ray in coronavirus disease-19 (COVID-19): A pictorial review10.1016/j.clinimag.2020.04.001 ↗
21. Thoracic imaging tests for the diagnosis of COVID-19
22. Asthma and COVID-19: Preconceptions about Predisposition10.1164/rccm.202102-0266ED ↗
23. Assessment and management of adults with asthma during the covid-19 pandemic10.1136/bmj.m2092 ↗
24. Asthmatic patients and COVID-19: Different disease course?10.1111/all.14601 ↗
25. Asthma and COVID-19: A systematic review10.1186/s13223-020-00509-y ↗
26. Asthma and viral infections: An intricate relationship10.1016/j.anai.2019.06.020 ↗
27. Managing adult asthma: The 2019 GINA guidelines10.3949/ccjm.87a.19136 ↗
28. Approaches to Asthma Diagnosis in Children and Adults10.3389/fped.2019.00148 ↗
29. Asthma Diagnosis: The Changing Face of Guidelines10.1007/s41030-019-0093-y ↗
30. GINA 2020: What’s new and why?10.1080/02770903.2020.1788076 ↗
31. The Global Initiative for Asthma (GINA): 25 years later10.1183/13993003.00598-2019 ↗
32. The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium10.1165/rcmb.2021-0364OC ↗
33. COVID-19 severity in asthma patients: A multi-center matched cohort study10.1080/02770903.2020.1857396 ↗
34. Asthma in patients with suspected and diagnosed coronavirus disease 201910.1016/j.anai.2021.02.020 ↗
35. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis10.1080/02770903.2021.1888116 ↗
36. Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis10.1016/j.jaip.2020.11.054 ↗
37. Does Asthma Increase the Mortality of Patients with COVID-19?: A Systematic Review and Meta-Analysis10.1159/000510953 ↗
38. Low prevalence of post-COVID-19 syndrome in patients with asthma10.1016/j.jinf.2021.03.023 ↗
39. Improved asthma control during the COVID-19 pandemic: Are there lessons to be learnt?10.1136/thoraxjnl-2021-216930 ↗
40. Reply Letter—COVID-19 (Novel Coronavirus 2019)—Recent trends
41. Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: A survey by the EAACI Asthma Section10.1111/all.14831 ↗
42. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence10.1016/j.ijantimicag.2020.105948 ↗
43. The SARS-CoV-2 outbreak: What we know10.1016/j.ijid.2020.03.004 ↗
44. A Review of Coronavirus Disease-2019 (COVID-19)10.1007/s12098-020-03263-6 ↗
45. Ashour, H.M., Elkhatib, W.F., Rahman, M.M., and Elshabrawy, H.A. (2020). Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. Pathogens, 9.10.3390/pathogens9030186 ↗
46. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness10.1016/j.jaip.2020.12.045 ↗
47. Lafaurie, M., Martin-Blondel, G., Delobel, P., Kamar, N., Charpentier, S., Sommet, A., and Moulis, G. (2021). Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19. BMC Pharmacol. Toxicol., 22.10.1186/s40360-021-00480-3 ↗
48. Inhaled corticosteroids and COVID-19: A systematic review and clinical perspective10.1183/13993003.01009-2020 ↗
49. Choi, J.C., Jung, S.Y., Yoon, U.A., You, S.H., Kim, M.S., Baek, M.S., Jung, J.W., and Kim, W.Y. (2020). Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study. J. Clin. Med., 9.10.3390/jcm9113406 ↗
50. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence10.1016/j.jaci.2021.06.006 ↗
51. Inhaled corticosteroids for the treatment of COVID-19
52. Dexamethasone in Hospitalized Patients with Covid-1910.1056/NEJMoa2021436 ↗
53. Asthma in patients with coronavirus disease 2019: A systematic review and meta-analysis10.1016/j.anai.2021.02.013 ↗
54. Uncontrolled asthma across GINA treatment steps 2 - 5 in a large US patient cohort10.1080/02770903.2021.1897834 ↗
55. New approach to intermittent and mild asthma therapy: Evolution or revolution in the GINA guidelines?10.1186/s13601-020-00316-z ↗
56. Motta, L.P., Silva, P., Borguezan, B.M., Amaral, J., Milagres, L.G., Bóia, M.N., Ferraz, M.R., Mogami, R., Nunes, R.A., and Melo, P.L. (2021). An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: Development and preliminary application. PLoS ONE, 16.10.1371/journal.pone.0247635 ↗
57. Acute asthma management during SARS-CoV2-pandemic 202010.1016/j.waojou.2020.100125 ↗
58. The outcomes and acceptance of pressurized metered-dose inhaler bronchodilators with venturi mask modified spacer in the outpatient emergency department during the COVID-19 pandemic10.1111/jcpt.13410 ↗
59. Risk of Transmitting Coronavirus Disease 2019 During Nebulizer Treatment: A Systematic Review
60. Tran, K., Cimon, K., Severn, M., Pessoa-Silva, C.L., and Conly, J. (2012). Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: A systematic review. PLoS ONE, 7.10.1371/journal.pone.0035797 ↗
61. An umbrella review: Corticosteroid therapy for adults with acute asthma10.1016/j.amjmed.2009.02.013 ↗
62. Corticosteroids for preventing relapse following acute exacerbations of asthma
63. Early emergency department treatment of acute asthma with systemic corticosteroids
64. The role of magnesium sulfate in the acute and chronic management of asthma10.1097/MCP.0b013e3282f19867 ↗
65. Prospects for severe asthma treatment10.1016/j.coph.2020.10.021 ↗
66. Acute severe asthma: New approaches to assessment and treatment10.2165/11319930-000000000-00000 ↗
67. Antibiotics for exacerbations of asthma
68. Control of asthma in real life: Still a valuable goal?10.1183/16000617.00001615 ↗
69. Clinical review: Severe asthma10.1186/cc1451 ↗
70. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy10.1080/17476348.2021.1917387 ↗
71. COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments10.1111/all.14532 ↗
72. Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection10.1016/j.jaip.2020.09.044 ↗
73. Brittle asthma
74. SARS-CoV-2 infection and COVID-19 in asthmatics: A complex relationship10.1038/s41577-021-00516-z ↗
75. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan10.1016/j.jaci.2020.04.006 ↗
76. Adjuvant corticosteroid therapy for critically ill patients with COVID-1910.1186/s13054-020-02964-w ↗
77. Meta-analysis of competitive antagonists in asthma treatment10.21037/apm-21-412 ↗
78. Triple therapy in uncontrolled asthma: A network meta-analysis of phase III studies10.1183/13993003.04233-2020 ↗
79. Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-1910.1111/all.14972 ↗
80. Phenotype-Guided Asthma Therapy: An Alternative Approach to Guidelines10.2147/JAA.S266999 ↗
81. Care of Respiratory Conditions in an Observation Unit10.1016/j.emc.2017.03.008 ↗
82. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: A modelling study10.1016/S2214-109X(20)30264-3 ↗
83. Follow-up after acute asthma episodes: What improves future outcomes?10.1016/j.jemermed.2009.06.109 ↗
84. Follow-up of patients with uncontrolled asthma: Clinical features of asthma patients according to the level of control achieved (the COAS study)10.1183/13993003.01885-2015 ↗
85. Bajowala, S., Shih, J., Varshney, P., and Elliott, T. (2022). The Future of Telehealth for Allergic Disease. J. Allergy Clin. Immunol. Pract.10.1016/j.jaip.2022.08.022 ↗
86. Shifts in Asthma Evaluation and Management During COVID-1910.1007/s40521-022-00304-7 ↗
87. COVID-19 (Novel Coronavirus 2019)—Recent trends
88. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)10.1111/all.14471 ↗
89. Asthma and severe acute respiratory syndrome coronavirus 2019: Current evidence and knowledge gaps10.1097/MCP.0000000000000744 ↗
90. Asthma and COVID-19: An update10.1183/16000617.0152-2021 ↗
91. Managing asthma in the COVID-19 pandemic and current recommendations from professional bodies: A review10.1080/02770903.2020.1804578 ↗
92. Management of asthma during the Coronavirus disease 2019 outbreak
93. British Toracic Society (2022, July 18). Advice for Healthcare Professionals Treating People with Asthma (Adults) in Relation to COVID-19. Available online: https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/bts-advice-for-healthcare-professionals-treating-patients-with-asthma/.
94. GINA Scientific Committee (2022, July 18). Global Strategy for Asthma Management and Prevention Updated 2022. Available online: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf.
95. National Asthma Council Australia (2022, July 18). Australian Asthma Handbook—Managing Asthma during the COVID-19 (SARS-CoV-2) Pandemic 2020. Available online: https://www.asthmahandbook.org.au/clinical-issues/covid-19.
96. Moher, D., Liberati, A., Tetzlaff, J., and Altman, D.G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6.10.1371/journal.pmed.1000097 ↗